WASHINGTON (Reuters) - The hardest-to-treat form of tuberculosis kills half the people who get it, according to a South Korean study that is one of the few to track survival rates from the condition ...

Only four out of 10 patients with extensively drug-resistant tuberculosis (TB) in Europe achieved successful treatment outcomes, a rate markedly lower than that for other forms of drug-resistant TB ...

In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis. The study found ...

For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.

In 2023 there were 100 cases of drug-resistant TB but a far smaller number of multidrug resistant disease. That year, there were just 15 cases of what’s called pre-extensively drug-resistant TB, and ...

ECDC report reveals tens of thousands of people remain undiagnosed while Europe’s multidrug-resistant tuberculosis (TB) rates ...

Tuberculosis (TB) continues to pose a serious public health challenge in Europe, even as some progress is being recorded. A ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

The study challenges the notion of a “one-size-fits-all” mechanism in bacterial transcription and highlights the diversity of regulatory strategies employed by pathogens.

Multi-drug-resistant tuberculosis is a public health concern in India, despite notable advancements in lowering the country's ...

Ahuja, S. D., D. Ashkin, M. Avendano, R. Banerjee, M. Bauer, J. N. Bayona, M. C. Becerra, A. Benedetti, M. Burgos, R. Centis, E. D. Chan, C. Y. Chiang, H. Cox, L. D ...